Skip to content

Docs (opens in a new tab)Pricing Ideas Benchmark

Sign in Sign up

N

NXTC

NextCure, Inc.

NASDAQHealthcareBiotechnologyUS

NASDAQ · Healthcare · Biotechnology · US

$6.66

+5.05%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsIdeas

Research · Sep 3, 2026
NXTC: FY25 Deep Dive
NextCure FY25 at $0M. NI $-56M; EPS $-19.65.

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Workspace|Docs (opens in a new tab)|Pricing|Research|Methodology|Privacy|Disclaimer|Contact|© 2026 LIL GREBE INC.